Lee H.-L.Lai S.-K.PEI-LUNG CHENChu C.-C.2021-07-062021-07-0620172059-2302https://www.scopus.com/inward/record.uri?eid=2-s2.0-85028948985&doi=10.1111%2ftan.13093&partnerID=40&md5=3b8bd8aaabfa4085d43072d8be3db0aehttps://scholars.lib.ntu.edu.tw/handle/123456789/569537The HLA-B*40:238 allele has one non-synonymous transversion from HLA-B*40:01:01 at nucleotide position 484. ? 2017 John Wiley & Sons A/S. Published by John Wiley & Sons LtdHLA-B*40:238; new allele; sequencing-based typing[SDGs]SDG3HLA B antigen; HLA B13 antigen; HLA B40 antigen; peptide; serine; threonine; HLA B40 antigen; agranulocytosis; allele; Article; gene conversion; gene identification; Graves disease; human; nucleotide sequence; nucleotide sequence; point mutation; polymerase chain reaction; protein binding; structural homology; Taiwanese; amino acid substitution; case report; chemistry; codon; DNA sequence; exon; gene expression; genetics; genotype; histocompatibility test; immunology; pathology; sequence alignment; single nucleotide polymorphism; Taiwan; Alleles; Amino Acid Substitution; Base Sequence; Codon; Exons; Gene Expression; Genotype; Graves Disease; Histocompatibility Testing; HLA-B40 Antigen; Humans; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Sequence Alignment; Sequence Analysis, DNA; Taiwanjournal article10.1111/tan.13093287151112-s2.0-85028948985